HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31

Hinge Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$103.96+4.80 (+4.84%)

Close on Oct 19, 2026

Market cap: $8.67B
P/E (TTM): –
Dividend yield: –

Hinge Health, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenue	588	390	293
Cost of Revenue	120	91	99
Gross Profit	468	300	194
Research & Development	368	101	110
Selling, General & Admin	646	231	215
Selling & Marketing	317	167	148
General & Administrative	330	64	67
Advertising Expenses	54	37	24
Operating Expenses	1,015	332	325
Operating Income	-546	-32	-131
Other Non-Operating Income	19	21	22
Asset Impairment Charges	0	0	0
Pretax Income	-527	-11	-109
Income Tax Expense	1.00	0.68	-0.41
Net Income	-528	-12	-108
Net Income to Common	-424	-12	-108
EPS (Basic)(per share)	-7.77	-0.88	-8.31
EPS (Diluted)(per share)	-7.77	-0.88	-8.31
Shares Outstanding (Basic, Weighted)(shares)	55	14	13
Shares Outstanding (Diluted, Weighted)(shares)	55	14	13
EBITDA	-541	-26	-125
Provision for Credit Losses	3.06	5.41	4.86

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 84.5%
Operating margin: 13.0%
Net margin: 15.1%
Return on equity, FY2025: 412.9%

Financial strength

Current ratio: 1.34
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 59.5%

Valuation

P/E ratio: –
Price to sales: 12.04
Price to book: 25.19
Dividend yield: –